|
|
Article: ProMetic and Halozyme Enter Into Long-Term Supply Agreement.
- Article from:
- Marketwire Canada
- Article date:
- November 9, 2009
CopyrightCOPYRIGHT 2009 Canadian Corporate News. News Provided by Comtex. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MONTREAL, QUEBEC, Nov 9, 2009 (Marketwire via COMTEX) -- ProMetic Life Sciences Inc. (TSX:PLI)("ProMetic") announced today that Halozyme Therapeutics, Inc. (Nasdaq:HALO)("Halozyme") and ProMetic have entered into a long-term supply agreement for a proprietary synthetic ligand affinity adsorbent manufactured by ProMetic's UK subsidiary, ProMetic BioSciences Ltd.
The agreement is for an initial five-year term with the opportunity for future extension. Other aspects of the agreement were not disclosed for reasons of client confidentiality. The synthetic ligand adsorbent provided under the supply agreement is used by Halozyme in the manufacture of its rHuPH20 ...